Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mu opiate receptor, also known as the μ-opioid receptor (MOR), is a member of the opioid receptor family and plays a central role in mediating the effects of endogenous opioids and opioid drugs. It is primarily responsible for analgesia, euphoria, respiratory depression, miosis, decreased gastrointestinal motility, and dependence.
Activation of the μ-opioid receptor leads to activation of inhibitory G proteins (Gi/Go), inhibition of adenylate cyclase activity, decreased cAMP levels, opening of potassium channels, and closing of calcium channels, resulting in reduced neuronal excitability.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mu Opiate Receptor (MOR).